Hepatitis C Virus Infection in Dialysis Patients

被引：12
作者：
Khedmat, Hossein [1 ]
Amini, Mohsen [1 ]
Ghamar-Chehreh, Mohammad Ebrahim [1 ]
Agah, Shahram [2 ]
机构：
[1] Baqiyatallah Univ Med Sci, Baqiyatalah Res Ctr Gastroenterol & Liver Dis, Tehran, Iran
[2] Univ Tehran Med Sci, Colorectal Res Ctr, Tehran, Iran
来源：
SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION | 2014年 / 25卷 / 01期
关键词：
D O I：
10.4103/1319-2442.124455
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Despite the introduction of strict hygienic precautions preventing infection spread of hepatitis C virus (HCV) in dialysis settings, this infection is still prevalent among dialysis patients due to procedures making the patients vulnerable to infection through blood contamination. Treatment of HCV infection in dialysis patients is also less successful than that in the non-uremic population due to contraindication of using ribavirin, a main drug, in the infected patients. In this review article we aim to investigate the feasibility of the current antiviral therapies in dialysis patients infected with HCV infection.
引用
收藏
页码：1 / 8
页数：8
相关论文
共 61 条
[1]   Quality of life in hemodialysis patients: hepatitis C virus infection makes sense [J].
Afsar, Baris ;
Elsurer, Rengin ;
Sezer, Siren ;
Ozdemir, Nurhan F. .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2009, 41 (04) :1011-1019
[2]  
Al Balwi MA, 2011, SAUDI J KIDNEY DIS T, V22, P712
[3]  
Alavian SM, 2007, HEPAT MON, V7, P153
[4]   A shield against a monster: Hepatitis C in hemodialysis patients [J].
Alavian, Seyed-Moayed .
WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (06) :641-646
[5]   Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience [J].
Alsaran, Khalid ;
Sabry, Alaa ;
Shaheen, Naila .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2011, 43 (03) :865-873
[6]   Management of HCV infection in chronic kidney disease [J].
Aoufi Rabih, S. ;
Garcia Agudo, R. .
NEFROLOGIA, 2011, 31 (03) :260-267
[7]   Changes in viremia and circulating interferon-α during hemodialysis in hepatitis C virus-positive patients:: Only coincidental phenomena? [J].
Badalamenti, S ;
Catania, A ;
Lunghi, G ;
Covini, G ;
Bredi, E ;
Brancaccio, D ;
Salvadori, M ;
Como, G ;
Ponticelli, C ;
Graziani, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (01) :143-150
[8]   Effect of Dialysis Modality on Survival of Hepatitis C-Infected ESRF Patients [J].
Bose, Bhadran ;
McDonald, Stephen P. ;
Hawley, Carmel M. ;
Brown, Fiona G. ;
Badve, Sunil V. ;
Wiggins, Kathryn J. ;
Bannister, Kym M. ;
Boudville, Neil ;
Clayton, Philip ;
Johnson, David W. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (11) :2657-2661
[9]  
Buargub M, 2006, SAUDI J KIDNEY DIS T, V17, P338
[10]  
Dzekova-Vidimliski P, 2011, BRATISL MED J, V112, P568
1234567